Contribution Agreements in the Pharmaceuticals Industry
14 Contracts & Agreements
- Akorn (1 contract)
- ARVINAS, INC. (1)
- Boston Therapeutics, Inc. (1)
- Cerecor Inc. (1)
- CorMedix Inc. (1)
- Evolus, Inc. (1)
- Innoviva, Inc. (1)
- Semnur Pharmaceuticals, Inc. (1)
- TFF Pharmaceuticals, Inc. (1)
- Valera Pharmaceuticals Inc (1)
- Wave Life Sciences Ltd. (4)
- Contribution and Satisfaction of Indebtedness Agreement, dated as of August 30, 2024 by and between Scilex Holding Company and Semnur Pharmaceuticals, Inc (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
- Contribution Agreement, dated November 1, 2019, by and between Cerecor Inc., Armistice Capital Master Fund, Ltd. And Avadel US Holdings Inc (Cerecor Inc., Filed With SEC on November 4, 2019)
- Contribution and Subscription Agreement dated January 24, 2018 between the Registrant and Lung Therapeutics, Inc (TFF Pharmaceuticals, Inc., Filed With SEC on August 20, 2019)
- Arvinas IP Contribution Agreement Agreement between Arvinas Operations, Inc. and Protag LLC, dated July 16, 2019 (ARVINAS, INC., Filed With SEC on August 5, 2019)
- Form of Contribution Agreement between Boston Therapeutics, Inc., CureDM Group, LLC and the members of CureDM Group Holdings, LLC dated January 1, 2018 (Boston Therapeutics, Inc., Filed With SEC on February 12, 2018)
- Contribution Agreement, dated as of October 3, 2013, by and among Strathspey Crown Holdings, LLC, the Registrant, the Shareholders of the Registrant, and J. Christopher Marmo, as... (Evolus, Inc., Filed With SEC on January 9, 2018)
- SCHEDULE 1 The Financial Contribution (Wave Life Sciences Ltd., Filed With SEC on November 6, 2015)
- SCHEDULE 1 The Financial Contribution (Wave Life Sciences Ltd., Filed With SEC on November 6, 2015)
- SCHEDULE 1 The Financial Contribution (Wave Life Sciences Ltd., Filed With SEC on October 9, 2015)
- SCHEDULE 1 The Financial Contribution (Wave Life Sciences Ltd., Filed With SEC on October 9, 2015)
- SALE AND CONTRIBUTION AGREEMENT dated as of April 17, 2014 between THERAVANCE, INC., as the Transferor and LABA ROYALTY SUB LLC, as the Transferee (Innoviva, Inc., Filed With SEC on April 21, 2014)
- AMENDMENT NO. 3 TO CONTRIBUTION AGREEMENT (CorMedix Inc., Filed With SEC on November 10, 2011)
- CONTRIBUTION AGREEMENT (Valera Pharmaceuticals Inc, Filed With SEC on March 14, 2005)
- STRIDES CAPITAL CONTRIBUTION AGREEMENT Buffalo Grove, Illinois $ 1,250,000.00September 22, 2004 (Akorn, Filed With SEC on September 27, 2004)
